Investigate the Relationship Between Inflammatory and Coagulation in SAH CSF
NCT ID: NCT04938414
Last Updated: 2022-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2020-12-01
2021-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
NCT04998370
Evaluation of Cerebral Spinal Fluid and Blood in Patients With Subarachnoid Hemorrhage
NCT00593268
The Role of Meningeal Lymphatic Vessels in the Absorption of Chronic Subdural Hematoma and Its Injury Mechanism
NCT05426889
Radiological Changes of Glymphatic-meningeal Lymphatic Drainage System After Subarachnoid Hemorrhage
NCT06444438
Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients
NCT01292278
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1.40 patients with SAH will be included. The CSF will used for ELISA test for inflammatory factors and cogulation factors.
2.CSF obtained from 4 patients with non-neuroloogical disease with 4 addittional SAH patients will be used for Mass Spectrometry
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subarachnoid hemorrhage
Patients with subarachnoid hemorrhage
Lumbar puncture
Lumbar puncture to obtain the cerebrospinal fluid and for diagnostic test
Control
patients with non-neurological diseases
Lumbar puncture
Lumbar puncture to obtain the cerebrospinal fluid and for diagnostic test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lumbar puncture
Lumbar puncture to obtain the cerebrospinal fluid and for diagnostic test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuanjian Fang, M.D
Role: STUDY_CHAIR
Zhejiang Univerisity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second affiliated hosipital of zhejiang univerisity school of medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-892
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.